Hims & Hers is under scrutiny for promoting compounded weight-loss drugs in a Super Bowl ad without clear FDA approval or side effect disclosures. These compounded drugs, unlike generics ...

Hims & Hers’ Super Bowl ad plugs its compounded weight loss drugs as the “affordable” solution to a “sick system,” but many concerns about safety still swirl around these forms of the ...

Health Canada has issued a recall notice for compounded drugs containing semaglutide, which is a key component in popular medications like Ozempic and Wegovy. The notice was issued on Tuesday ...

On June 7, 2002, the FDA issued a compliance policy guidance to FDA staff and the drug compounding industry to explain how it will regulate pharmacy compounding in the immediate future in light of ...

In preclinical studies, when this photoreactive compound was administered to mice with drug-resistant pancreatic cancer and subsequently exposed to infrared light, the results were striking.

Hims & Hers sells a compounded weight loss medication. A telehealth company that sells a compounded version of medications used for weight loss has found itself at the center of an escalating ...

And last year, the FDA issued warnings about the drugs, but they haven’t been recalled and remain readily available. So, what is going on with compounded semaglutide, and is it safe? How can you ...

A whistleblower can advance claims that Maryland-based Blair Pharmacy Inc. and its owner violated the False Claims Act by submitting false prescription claims for compound drugs to Medicare and ...

Digital health company Noom has launched a compound pharmacy-made version of Novo Nordisk's obesity drug semaglutide to make the drug more accessible to consumers in the US. The bold move has been ...

Set to the tune of Childish Gambino’s “This Is America,” the 60-second spot, which reportedly cost between $14 million and $16 million to air during the big game, is plugging “affordable” versions of ...